National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Biopreserv Biobank. 2024 Apr;22(2):174-178. doi: 10.1089/bio.2023.0001. Epub 2023 Aug 3.
PAXgene Blood RNA tubes are routinely used in clinical research and molecular biology applications to preserve the stability of RNA in whole blood. However, in practice, blood clots are occasionally observed after blood collection and are often ignored. Currently, there are few studies on whether blood clots affect the quality of RNA extracted from these tubes. Fifteen pairs of non-clot and clot PAXgene Blood RNA tube samples ( = 30) were collected to form two matched groups from 15 patients. According to the maximum diameter () of the blood clot observed visually at the time of sample reception, the clot groups were divided into a small-clot group (0 cm < < 0.5 cm) and a large-clot group ( ≥ 0.5 cm). RNA was extracted by the PAXgene Blood RNA Kit. To analyze the quality of RNA, its yield and purity were assessed by spectrophotometry, and integrity was measured by microfluidic electrophoresis. An A ratio between 1.8 and 2.2 indicated purified RNA, and RNA integrity number (RIN) values ≥7.0 were considered to represent qualified integrity. The median yields of RNA from the non-clot and clot groups were 3.84 (2.80-6.38) μg and 4.87 (2.77-8.30) μg, respectively. The median A ratios were 2.08 (2.06-2.09) and 2.09 (2.07-2.11), whereas the median A ratios were 1.77 (1.31-1.91) and 1.67 (1.21-1.94) in the two groups. In addition, the median RINs were 8.20 (8.00-8.40) and 7.20 (6.60-7.70), respectively. There were no significant differences in RNA yields, A, or A between the two groups. However, the RIN value of the clot group was significantly lower compared with the non-clot group ( < 0.05), with RIN ≥7.0 found in all non-clot samples and 60% of clot samples ( < 0.05). Furthermore, in the clot groups, the small-clot samples had higher RIN values than large-clot samples (8.25 [7.75-8.75] vs. 6.90 [6.60-7.30], < 0.001). The formation of large blood clots in PAXgene Blood RNA tubes will reduce the integrity of extracted RNA.
PAXgene Blood RNA 管在临床研究和分子生物学应用中通常用于保存全血中 RNA 的稳定性。然而,在实践中,采集后偶尔会观察到血液凝块,并且通常会被忽略。目前,关于血液凝块是否会影响从这些管中提取的 RNA 的质量的研究很少。从 15 名患者中收集了 15 对非凝块和凝块 PAXgene Blood RNA 管样本( = 30),以形成两个匹配组。根据样本接收时肉眼观察到的血液凝块的最大直径(),将凝块组分为小凝块组(0 cm < < 0.5 cm)和大凝块组( ≥ 0.5 cm)。使用 PAXgene Blood RNA 试剂盒提取 RNA。为了分析 RNA 的质量,通过分光光度法评估其产量和纯度,并通过微流控电泳测量其完整性。A 比在 1.8 和 2.2 之间表示纯化的 RNA,并且 RNA 完整性编号(RIN)值≥7.0 被认为表示合格的完整性。非凝块组和凝块组的 RNA 中位产量分别为 3.84(2.80-6.38)μg 和 4.87(2.77-8.30)μg。A 比的中位数分别为 2.08(2.06-2.09)和 2.09(2.07-2.11),而两组的 A 比中位数分别为 1.77(1.31-1.91)和 1.67(1.21-1.94)。此外,RIN 的中位数分别为 8.20(8.00-8.40)和 7.20(6.60-7.70)。两组间 RNA 产量、A 或 A 无显著差异。然而,凝块组的 RIN 值明显低于非凝块组( < 0.05),所有非凝块样本的 RIN 值均≥7.0,而 60%的凝块样本( < 0.05)。此外,在凝块组中,小凝块样本的 RIN 值高于大凝块样本(8.25 [7.75-8.75] vs. 6.90 [6.60-7.30], < 0.001)。PAXgene Blood RNA 管中较大的血液凝块的形成会降低提取 RNA 的完整性。